The Maxisys Ultra is a diagnostic tool with Android 7.0, it also features a 13-inch touchscreen tablet with an octa-core processor (2.3GHz quad-core + 1.7GHz quad-core), 256GB of built-in RAM, all of which support new split-screen multi-app navigation, diagnostic guidance and test kits to confirm repairs.
The all new MaxiSYS Ultra is the first diagnostic tool to be designed to match the growth of more complex automotive electrical systems and Electric Vehicles (EV) which are becoming ever more common place. MS Ultra provides the latest OE level coverage for most domestic and foreign vehicles, with advanced ECU coding and programming automatic system and software update.

Autel Maxisys Ultra Scanner BULLET POINTS
Easy to Use: The Ultra has a super large screen, See: launch obd2 review. our fastest processors, our largest ever SSD memory and even a docking station as standard.
Full Function: includes outstanding coverage with 80+ manufacturers, full diagnostics, 26 service functions, channel coding and programming.
Thoughtful Design: Android 7.0 with 13-inch TFT-LCD with 2732 x 2048 resolution & capacitive touchscreen tablet bring you excellent use experience.
Step-by-step Guidance: Offering step-by-step repair guidance for technicians, ULTRA combines dynamic topology module mapping, enhanced automatic scanning capabilities, and intelligent diagnostic options.
More Click: Autel MaxiSys Ultra Review

Posted by: autelds708 at 01:38 PM | No Comments | Add Comment
Post contains 212 words, total size 2 kb.

BERLIN (AP) - Germany announced Sunday that travelers from France's northeastern Moselle region will face additional restrictions because of the high rate of variant coronavirus cases there.
Germany's disease control agency, the Robert Koch Institute, said it would add Moselle to the list of "variant of concern" areas that already includes countries such as the Czech Republic, Portugal, the United Kingdom and parts of Austria.
Travelers from those areas must produce a recent negative coronavirus test before entering Germany.
The Moselle region in northeastern France includes the city of Metz and borders the German states of Saarland and Rhineland-Palatinate.
Clement Beaune, the French minister for European affairs, said France regrets the decision and is in negotiations with Germany to try to lighten the measures for 16, See: diagnostic code reader. 000 inhabitants of Moselle who work across the border. Specifically, he said France does not want them to face the daily PCR virus tests that Germany has applied elsewhere to travelers along some borders.
"We don't want that," he said.
Beaune said France is pushing for the use of easier, faster testing methods and for tests every 2-3 days rather than daily. More talks were expected later Sunday, he said.
The weekly rate of new infections in Moselle, at more than 300 per 100,000 people, is well above the average for France's eastern region and the national average. In Germany, the number of cases per week currently stands at almost 64 per 100,000 inhabitants.
The Robert Koch Institute recorded 7,890 newly confirmed cases of COVID-19 in Germany over the past day, taking the total to over 2.4 million cases. The death toll rose by 157 to 70,045.
German officials have warned that virus variants such as the one first detected in Britain - known as B.1.1.7 - could spread more easily and fuel the infection rate at a time when Germany is slowly relaxing its lockdown measures.
"There are two trains rushing toward each other," said Karl Lauterbach, an epidemiologist and lawmaker with the center-left Social Democrats.
He called for Germany to prioritize giving as many people as possible an initial vaccine dose, as some other countries have done, including with the AstraZeneca shot currently reserved for those under 65. Companies and schools should also carry out weekly tests, or more once possible, and those with a negative result should also be able to visit stores again.
Bavaria's governor, Markus Soeder, also urged a change to the way the AstraZeneca shot is used. The vaccine has been shunned by many hoping to get the shot made by German company BioNTech and Pfizer, or a similar one made by U.S. firm Moderna.
Soeder said Sunday it was "an absurd situation" that many who want to get vaccinated can't, while those who can don't want to.
"Whatever is left over should just be released," he said.
___
Follow all of AP's pandemic coverage at:
https://apnews.com/hub/coronavirus-pandemic
https://apnews.com/hub/coronavirus-vaccine
https://apnews.com/UnderstandingtheOutbreak

Posted by: autelds708 at 12:41 AM | No Comments | Add Comment
Post contains 494 words, total size 3 kb.